Associations between genetically predicted plasma protein levels and Alzheimer's disease risk: a study using genetic prediction models.
Published version
Peer-reviewed
Repository URI
Repository DOI
Type
Change log
Authors
Abstract
BACKGROUND: Specific peripheral proteins have been implicated to play an important role in the development of Alzheimer's disease (AD). However, the roles of additional novel protein biomarkers in AD etiology remains elusive. The availability of large-scale AD GWAS and plasma proteomic data provide the resources needed for the identification of causally relevant circulating proteins that may serve as risk factors for AD and potential therapeutic targets. METHODS: We established and validated genetic prediction models for protein levels in plasma as instruments to investigate the associations between genetically predicted protein levels and AD risk. We studied 71,880 (proxy) cases and 383,378 (proxy) controls of European descent. RESULTS: We identified 69 proteins with genetically predicted concentrations showing associations with AD risk. The drugs almitrine and ciclopirox targeting ATP1A1 were suggested to have a potential for being repositioned for AD treatment. CONCLUSIONS: Our study provides additional insights into the underlying mechanisms of AD and potential therapeutic strategies.
Description
Funder: Intramural Research Program of the National Institutes of Health (National Institute on Aging)
Funder: Florida State University; doi: http://dx.doi.org/10.13039/100006597
Funder: University of Hawaii Cancer Center
Keywords
Journal Title
Conference Name
Journal ISSN
1758-9193
Volume Title
Publisher
Publisher DOI
Sponsorship
British Heart Foundation (None)
British Heart Foundation (RG/18/13/33946)
National Institute for Health and Care Research (IS-BRC-1215-20014)
MRC (MC_PC_23013)
Medical Research Council (HDR-23007)